ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 220

A Genome-Wide Association Study Reveals Association of the Transferrin Receptor Locus with Gout

Tony R. Merriman1, Murray Cadzow2, Callum Tanner2, Matthew A. Brown3, Katie Cremin4, Matthijs Janssen5, Tim Jansen6, Leo A. Joosten7, Timothy Radstake8, Philip L. Riches9, Anne-Kathrin Tausche10, Frederic Lioté11, Alex So12,13, Andre M. van Rij2, Gregory T. Jones14, Lisa K. Stamp15, Nicola Dalbeth16 and Cushla McKinney2, 1Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand, 2University of Otago, Dunedin, New Zealand, 3The University of Queensland Diamantina Institute, Brisbane, Australia, 4Diamantina Institute, University of Queensland, Brisbane, Australia, 5Rheumatology Dept, Ziekenhuis Rijnstate, Arnhem, Netherlands, 6P O Box 581, Haarlem, Netherlands, 7Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 8Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 9Centre for Genomic and Experimental Medicine, Western General Hospital, Edinburgh, United Kingdom, 10Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, 11Rheumatology Department; Inserm UMR-S606; Paris-Diderot University, hôpital Lariboisiere, Paris, France, 12Service De Rhumatologie, CHUV, Lausanne, Switzerland, 13Department of Rheumatology, CHUV, Lausanne, Switzerland, 14Surgery, University of Otago, Dunedin, New Zealand, 15Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 16Department of Medicine, University of Auckland, Auckland, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Acute gouty arthritis results from an innate immune response to monosodium urate (MSU) crystals deposited in the joints and soft tissues of hyperuricaemic individuals. Genome-wide association studies (GWAS) have provided insight into the genetic control of urate homeostasis. However there have been very few genetic insights into the pathogenesis of acute gouty arthritis. Key checkpoints are expected to be in MSU crystal formation and immune response. The aim was to conduct a GWAS in gout using the immune-centric Immunochip.

Methods: 456 European patients with gout fulfilling the 1977 ARA gout classification criteria were genotyped with the Immunochip microarray, which contains single nucleotide variants (SNVs) at loci chosen largely on the basis of association with other immune-mediated phenotypes. SNVs out of Hardy Weinberg equilibrium (P<1×10-7) and with minor allele frequency <0.01 were discarded with 139,874 SNVs remaining. The genomic inflation factor was 1.06. Allele frequencies were compared by logistic regression using PLINK software to 1,000 European controls sourced from the 1958 British Birth Cohort. Replication was conducted using Taqman genotyping in 1,190 European cases with gout and 960 NZ controls, with additional data from 11,127 publically-available European controls, and Taqman genotyping of 931 Polynesian cases and 964 controls. For replication, logistic regression analyses were adjusted by age, sex and (for Polynesian) number of self-reported Polynesian grandparents. Replication sample sets were combined by meta-analysis using METAL software. Replication was declared at P<0.01.

Results: Five SNVs with P between 1×10-5 and 6×10-5 from the discovery GWAS were selected for replication (Table). Rs1466085, in the enhancer region 11kb upstream of the transferrin receptor (TFRC), was the only variant to replicate (OR=1.30, P=5×10-5) in a directionally consistent fashion to the discovery GWAS data (OR=1.77, P=3×10-5). Combining the discovery and replication sets yielded P=6.4×10-8 at rs1466085. There was no evidence for association of rs1466085 with serum urate levels in European controls (beta=0.003, P=0.18).

Conclusion: These data, with P=10-5 in both discovery and replication phases, convincingly implicate the region immediately upstream of the transferrin receptor in the etiology of gout in an urate-independent manner. It is important that further genetic fine-mapping and molecular expression experiments are done to confirm TFRC as the causal gene in the region.

Table Association of five genetic variants in the genome-wide (discovery) and replication analyses

Discovery (GWAS)

Replication

Disc and Rep

Nearest gene

Risk allele

MAF case/cont

OR

P

MAF case/cont

OR

P

OR, P

rs117561283

IFNG-AS1

T

0.052/0.024

2.28

6×10-5

EUR

POLY

COMB

0.027/0.021

0.003/0.007

1.32

1.06

1.31

0.062

0.94

0.067

1.57, 1.8×10-4

rs11761178

WBSCR28

A

0.456/0.370

1.43

1×10-5

EUR

POLY

COMB

0.394/0.410

0.775/0.751

0.90

1.01

0.92

0.030

0.91

0.060

–

rs1466085

TFRC

A

0.110/0.066

1.77

3×10-5

EUR

POLY

COMB

0.091/0.068

0.652/0.583

1.29

1.32

1.30

0.0022

0.0094

5×10-5

1.37, 6.4×10-8

rs1887406

ZBTB46

C

0.249/0.176

1.56

4×10-5

EUR

POLY

COMB

0.200/0.191

0.318/0.279

1.02

1.31

1.08

0.69

0.018

0.14

1.18, 4.9×10-4

rs6891250

SORCS2

C

0.176/0.120

1.57

5×10-5

EUR

POLY

COMB

0.125/0.125

0.303/0.315

0.98

0.90

0.96

0.80

0.34

0.45

1.07, 0.22


Disclosure: T. R. Merriman, None; M. Cadzow, None; C. Tanner, None; M. A. Brown, Abbvie, Pfizer, UCB, Wyeth, Leo Pharma, NIAMS, NHMRC, Arthritis Australia, Qld Government, 2,Pfizer, Abbvie, UCB, 5,Pfizer, Abbvie, UCB, 8; K. Cremin, None; M. Janssen, None; T. Jansen, None; L. A. Joosten, None; T. Radstake, None; P. L. Riches, Menarini, 2; A. K. Tausche, None; F. Lioté, None; A. So, None; A. M. van Rij, None; G. T. Jones, None; L. K. Stamp, None; N. Dalbeth, None; C. McKinney, None.

To cite this abstract in AMA style:

Merriman TR, Cadzow M, Tanner C, Brown MA, Cremin K, Janssen M, Jansen T, Joosten LA, Radstake T, Riches PL, Tausche AK, Lioté F, So A, van Rij AM, Jones GT, Stamp LK, Dalbeth N, McKinney C. A Genome-Wide Association Study Reveals Association of the Transferrin Receptor Locus with Gout [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-genome-wide-association-study-reveals-association-of-the-transferrin-receptor-locus-with-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-genome-wide-association-study-reveals-association-of-the-transferrin-receptor-locus-with-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology